Dahari H - Search Results

1

Modeling the Interplay between HDV and HBV in Chronic HDV/HBV Patients.

Mhlanga A, Zakh R, Churkin A, Reinharz V, Glenn JS, Etzion O, Cotler SJ, Yurdaydin C, Barash D, Dahari H. Mhlanga A, et al. Among authors: dahari h. Mathematics (Basel). 2022 Oct 2;10(20):3917. doi: 10.3390/math10203917. Epub 2022 Oct 21. Mathematics (Basel). 2022. PMID: 36540372 Free PMC article.

2

The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.

Sabahi A, Marsh KA, Dahari H, Corcoran P, Lamora JM, Yu X, Garry RF, Uprichard SL. Sabahi A, et al. Among authors: dahari h. Virology. 2010 Nov 10;407(1):110-9. doi: 10.1016/j.virol.2010.07.026. Epub 2010 Aug 25. Virology. 2010. PMID: 20800257 Free PMC article.

3

Treatment of hepatitis C with an interferon-based lead-in phase: a perspective from mathematical modelling.

Rong L, Guedj J, Dahari H, Perelson AS. Rong L, et al. Among authors: dahari h. Antivir Ther. 2014;19(5):469-77. doi: 10.3851/IMP2725. Epub 2014 Jan 16. Antivir Ther. 2014. PMID: 24434478 Free PMC article.

4

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.

Bouvier-Alias M, Patel K, Dahari H, Beaucourt S, Larderie P, Blatt L, Hezode C, Picchio G, Dhumeaux D, Neumann AU, McHutchison JG, Pawlotsky JM. Bouvier-Alias M, et al. Among authors: dahari h. Hepatology. 2002 Jul;36(1):211-8. doi: 10.1053/jhep.2002.34130. Hepatology. 2002. PMID: 12085367

5

Silymarin for HCV infection.

Polyak SJ, Oberlies NH, Pécheur EI, Dahari H, Ferenci P, Pawlotsky JM. Polyak SJ, et al. Among authors: dahari h. Antivir Ther. 2013;18(2):141-7. doi: 10.3851/IMP2402. Epub 2012 Sep 25. Antivir Ther. 2013. PMID: 23011959 Free PMC article. Review.

6

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.

Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Neumann AU, et al. Among authors: dahari h. Science. 1998 Oct 2;282(5386):103-7. doi: 10.1126/science.282.5386.103. Science. 1998. PMID: 9756471 Clinical Trial.

7

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.

Major ME, Dahari H, Mihalik K, Puig M, Rice CM, Neumann AU, Feinstone SM. Major ME, et al. Among authors: dahari h. Hepatology. 2004 Jun;39(6):1709-20. doi: 10.1002/hep.20239. Hepatology. 2004. PMID: 15185313

8

The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate.

Guedj J, Dahari H, Uprichard SL, Perelson AS. Guedj J, et al. Among authors: dahari h. Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):397-9. doi: 10.1586/17474124.2013.811050. Expert Rev Gastroenterol Hepatol. 2013. PMID: 23899277 Free PMC article. No abstract available.

9

Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells.

Dahari H, Ribeiro RM, Rice CM, Perelson AS. Dahari H, et al. J Virol. 2007 Jan;81(2):750-60. doi: 10.1128/JVI.01304-06. Epub 2006 Oct 11. J Virol. 2007. PMID: 17035310 Free PMC article.

10

Antiviral action of ribavirin in chronic hepatitis C.

Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, Lonjon I, Castera L, Dhumeaux D. Pawlotsky JM, et al. Among authors: dahari h. Gastroenterology. 2004 Mar;126(3):703-14. doi: 10.1053/j.gastro.2003.12.002. Gastroenterology. 2004. PMID: 14988824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page